AKT1 and type 2 diabetes mellitus: These targets mainly focus on the PI3K-Akt signaling pathway related to T2DM, AGE-RAGE signaling pathway in diabetic complications, tumor necrosis factor (TNF) signaling pathway, and insulin resistance.